Adherence with urate-lowering therapies for the treatment of gout.
about
2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemiaGout: optimizing treatment to achieve a disease cureMedication adherence in gout: a systematic reviewAllopurinol: insights from studies of dose-response relationships.Patients' knowledge and beliefs concerning gout and its treatment: a population based study.The dynamics of chronic gout treatment: medication gaps and return to therapyHealth care utilization in patients with gout: a prospective multicenter cohort study2011 recommendations for the diagnosis and management of gout and hyperuricemia.Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout.The impact of gout on patient's lives: a study of African-American and Caucasian men and women with gout.Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies.Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort.Health-related quality of life and treatment satisfaction in patients with gout: results from a cross-sectional study in a managed care setting.Effect of Urate-Lowering Therapy on All-Cause and Cardiovascular Mortality in Hyperuricemic Patients without Gout: A Case-Matched Cohort StudyThe pharmacokinetics of oxypurinol in people with gout.Modifiable factors associated with allopurinol adherence and outcomes among patients with gout in an integrated healthcare systemPredictors of medication non-adherence for vasculitis patientsPoorly controlled gout: who is doing poorly?Improving treatment adherence in patients with rheumatologic disease.Understanding the dose-response relationship of allopurinol: predicting the optimal dosage.Utility of the Morisky Medication Adherence Scale in gout: a prospective study.Factors associated with initiation and persistence of urate-lowering therapy.Managing your patient with gout: a review of treatment options.Difficult-to-treat gouty arthritis: a disease warranting better management.Recent advances in management of gout.Hyperuricemia and gout: new concepts in diagnosis and management.Prophylaxis for acute gout flares after initiation of urate-lowering therapy.Management of gout in general practice--a systematic review.Advances in pharmacotherapy for the treatment of gout.Investigational drugs for hyperuricemia.Gouty arthropathy: Review of clinico-pathologic and imaging features.Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis.Factors influencing medication adherence in patients with gout: A descriptive correlational study.Target Serum Urate: Do Gout Patients Know Their Goal?Management of gout in the real world: current practice versus guideline recommendations.A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift.Gout Self-Management in African-American Veterans: A Qualitative Exploration of Challenges and Solutions from Patients' Perspectives.Education Preferences of People with Gout: Exploring Differences Between Indigenous and Non-Indigenous Peoples from Rural and Urban Locations.Adherence with urate-lowering therapies among male patients with gout in a routine clinical setting.Rationale and design of the randomized evaluation of an Ambulatory Care Pharmacist-Led Intervention to Optimize Urate Lowering Pathways (RAmP-UP) Study.
P2860
Q24612292-65F4A42F-4C76-414D-80E9-A8D731DCDB99Q26765550-5D8BA4BC-12DB-4466-9323-B651DF276DC6Q27694691-8A997162-84E4-4652-9A13-503D0996FEC9Q30240163-47BADF8D-848D-4013-ACA7-41191BFB0439Q31096665-29A93D56-B64E-43E0-9108-E0762688081CQ33617747-D8EF517E-F2FF-4FB2-856C-2EDDC5215952Q33750100-34807CBA-FC26-4317-B388-5F775851BA3DQ34250995-352DC29D-458C-4272-B56B-074DAEFCDCCEQ34415029-65C1E6DB-84B1-402F-B7AB-E012BFC15588Q34502543-ABDEA324-384C-4608-B01E-D2A93E9351F6Q35503271-85BC032A-38F8-4840-8C07-53A6900721D5Q35595259-38C2787F-A560-443C-BABE-E7EFB34E0753Q35849062-F02AE6C5-77C0-45F6-AD70-D180503857E4Q35873062-48B7B541-50D7-4FB1-9231-19BE3C4C0458Q36336035-9797B2F8-2DB7-4BA8-B7B8-18AEE550167EQ37041741-AF0D00EC-837E-415A-874C-73A1B5CB6563Q37094772-F64F8A7B-760C-40BC-88A1-9BAF1B9EBF5EQ37195376-E04BA9F0-4946-471A-8A2C-C9B03218AD1CQ37196980-8D93493A-4915-419D-A88D-412AA9B75B3AQ37353448-C5EBFB3E-99EF-4DAA-8ACA-2EF758988321Q37485303-C82DC2CA-00EA-4CBF-925D-930120A09555Q37589104-0535B866-BB4F-43F3-AABB-EA50068D166BQ37874889-745E6392-600D-4E97-ACB0-63EE40E75325Q37910901-F8BB7D92-F61C-43D4-A06E-665F1863B540Q37971360-EF833B73-A7F8-4D47-89DA-822485F02DE7Q38074338-F336E7A3-0CCE-46A0-A369-1209C414F223Q38206603-7FC11EBF-041B-41C3-A9CD-ED56F9C2DA46Q38249921-5658BCD8-4199-40C8-A968-74ACB375EC36Q38303416-0A3EEFD3-3B32-4C18-9151-49A395D8F682Q38527441-CC604090-B976-4ADF-A9E9-C73D8D6853BAQ38599956-7F72A337-B141-4177-8E1A-719B96B63BBEQ38669137-27D724C0-AD9E-4861-B5D6-BC4649DFEAC3Q38670679-AA883F27-059C-4D13-AB1F-C160D0028C6FQ40089909-38F95F44-F8BF-464D-8D1C-2E8A2D4B659DQ40291328-46A6EC68-8A33-4B7A-9FF3-10878A7C29DAQ40311349-419275B7-1CBD-4B7E-8646-3934FDF7947CQ40366290-43EE8B76-9D90-422E-B272-DE0DEF864052Q40465860-AD146120-5F2E-42C7-9904-6153245234FBQ40770483-46CDB7DC-D394-4008-A025-FD7F28603CA0Q41174839-E6AD4772-EF63-4D16-BF09-0307397ECA4A
P2860
Adherence with urate-lowering therapies for the treatment of gout.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adherence with urate-lowering therapies for the treatment of gout.
@en
Adherence with urate-lowering therapies for the treatment of gout.
@nl
type
label
Adherence with urate-lowering therapies for the treatment of gout.
@en
Adherence with urate-lowering therapies for the treatment of gout.
@nl
prefLabel
Adherence with urate-lowering therapies for the treatment of gout.
@en
Adherence with urate-lowering therapies for the treatment of gout.
@nl
P2093
P2860
P356
P1476
Adherence with urate-lowering therapies for the treatment of gout.
@en
P2093
Becky A Briesacher
Hassan Fouayzi
Ira S Ockene
Leslie R Harrold
Marsha A Raebel
Robert A Yood
Susan E Andrade
P2860
P2888
P356
10.1186/AR2659
P577
2009-03-27T00:00:00Z
P5875
P6179
1023568855